Newsletter insight
Philips Sets Aside €288 Million for US Sleep Apnoea Probe
Perspectives from the HPC business newsletter.
← All business news
On 3 November, Philips reported setting aside €288 million to settle a US investigation related to its sleep apnoea business. The development highlights the importance of product safety, compliance and risk management in medical technology.
On 3 November, Philips reported setting aside €288 million to settle a US investigation related to its sleep apnoea business. The development highlights the importance of product safety, compliance and risk management in medical technology.
Healthcare manufacturers, regulatory advisers and medical-device suppliers can explore compliance and service opportunities. HPC can support relevant industry connections.